Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: J Public Health Manag Pract. 2014 Mar-Apr;20(2):E7–E15. doi: 10.1097/PHH.0b013e3182a0b8c7

Table 1. Differences in smoking abstinence by use of nicotine replacement therapy among smokers who completed the 12- and 26-week posttests.

Any Use of NRT Duration of Use of NRT
Used Did Not Use More than 2 weeks 1 to 2 weeks Did Not Use
12-week posttest
N 922 415 420 502 415
30-day point prevalence abstinence 19.4% 8.0%** 29.1% 11.4% 8.0%**
26-week posttest
N 774 261 408 366 261
30-day point prevalence abstinence 22.0% 18.4% 31.4% 11.5% 18.4%**
Continuous abstinence 8.9% 5.0%* 12.5% 4.9% 5.0%**
*

p<.05;

**

p<.001